New Market Study: "Brinavess (Atrial Fibrillation) - Analysis and Forecasts to 2022"
GlobalData's pharmaceuticals report, "Brinavess (Atrial Fibrillation) - Analysis and Forecasts to 2022" provides Brinavess global sales estimates. In addition, it covers detailed clinical assessment of the drug, factors impacting drug sales, competitive landscape, and analysis of sales performance during the forecast period (2010-2022). The report also includes information on Atrial Fibrillation market. This report is built using data and information sourced from GlobalData's proprietary databases, primary and secondary research using Company's corporate website, SEC filings, investor presentations and featured press...
View full press release